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ABSTRACT  57 
AIMS – To investigate whether 1) six weeks of high-intensity interval training (HIT) 58 
induces similar improvements in cardio-metabolic health markers as moderate-59 
intensity continuous training (MICT) in people with type 1 diabetes, and 2) whether 60 
HIT abolishes acute reductions in plasma glucose observed following MICT sessions. 61 
METHODS – Fourteen sedentary individuals with type 1 diabetes (n=7 per group) 62 
completed six weeks of HIT or MICT 3 times per week. Pre- and post-training 63 
measurements were made of 24h interstitial glucose profiles (using continuous 64 
glucose monitors (CGMS)) and cardio-metabolic health markers (?̇?O2peak, blood lipid 65 
profile and aortic pulse wave velocity; aPWV). Capillary blood glucose 66 
concentrations were assessed before and after exercise sessions throughout the 67 
training programme to investigate changes in blood glucose during exercise in the 68 
fed state.  69 
RESULTS – Six weeks of HIT or MICT increased ?̇? O2peak by 14% and 15%, 70 
respectively (P<0.001), and aPWV by 12% (P<0.001), with no difference between 71 
groups. 24h CGMS data revealed no differences in incidence or percentage of time 72 
spent in hypoglycaemia following training in either group (P>0.05). In the fed state, 73 
the mean change in capillary blood glucose concentration during the HIT sessions 74 
was -0.2±0.5 mmol/L, whereas blood glucose change was -5.5±0.4 mmol/L during 75 
MICT. 76 
CONCLUSIONS - Six weeks of HIT improved ?̇?O2peak and aortic PWV to a similar 77 
extent as MICT. The finding that blood glucose remained stable during HIT in the fed 78 
state, but consistently fell during MICT, suggests that HIT may be the preferred 79 
training mode for some people with type 1 diabetes.  80 
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INTRODUCTION 81 
Regular exercise is recommended for people with type 1 diabetes to maintain overall 82 
health and reduce the risk of macrovascular and microvascular complications, which 83 
are a major cause of mortality and morbidity1,2. The current guidelines for people 84 
with type 1 diabetes are to undertake at least 150 minutes of moderate to vigorous 85 
aerobic exercise per week, spread over at least three days per week, with no more 86 
than two consecutive days without activity3. Benefits of exercise for those with type 1 87 
diabetes include improved aerobic capacity ( ?̇? O2max), insulin sensitivity, body 88 
composition, endothelial function and blood lipid profile1,4-6. Despite the benefits, few 89 
people with type 1 diabetes achieve exercise targets and many programmes 90 
designed to increase physical activity have failed7,8. In addition to the barriers to 91 
exercise cited by the general population, such as a perceived lack of time, work 92 
commitments and cost9, people with type 1 diabetes face additional barriers 93 
including fear of hypoglycaemia, loss of glycaemic control and inadequate 94 
knowledge around exercise management10,11.  95 
 To overcome a perceived lack of time, high intensity interval training (HIT) is 96 
purported as a time-efficient alternative to moderate-intensity exercise to improve 97 
numerous cardio-metabolic risk factors including ?̇? O2max, insulin sensitivity and 98 
glycaemic control in people without type 1 diabetes12,13. Furthermore, results from 99 
our laboratory show that a single bout of HIT does not increase the risk of 100 
hypoglycaemia in people with type 1 diabetes (Scott et al. unpublished observations, 101 
see supplementary material14). Whether HIT offers a safe, effective and time-efficient 102 
training strategy to improve cardio-metabolic health that reduces the risk of 103 
hypoglycaemia in people with type 1 diabetes is yet to be investigated.  104 
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Here we investigated the hypothesis that six weeks of HIT would improve 105 
markers of cardio-metabolic health, including ?̇?O2peak, glycaemic control, blood lipid 106 
profile and vascular health in people with type 1 diabetes. A moderate intensity 107 
continuous training (MICT) group was used as a control. During this 6-week training 108 
period capillary blood glucose concentrations were monitored before and after 109 
exercise sessions to provide further information on the acute effects of HIT and 110 
MICT on blood glucose concentration.  111 
 112 
RESEARCH DESIGN AND METHODS 113 
Fourteen previously sedentary people with type 1 diabetes (10 men/4 women; see 114 
Table 1 for participant characteristics) on a basal-bolus insulin regimen completed 115 
six weeks of supervised HIT (n=7) or MICT (n=7) three times per week. Participants 116 
were pair-matched based on sex, age and ?̇? O2peak to the two training groups. 117 
Exclusion criteria were duration of type 1 diabetes <6 months, insulin pump therapy, 118 
poor diabetes control (HbA1c >86 mmol/mol), frequent hypoglycaemia (>5 per week) 119 
and/or hypo-unawareness (determined from medical history), obesity (BMI >30 kg∙m-120 
2), pregnancy or planning pregnancy, uncontrolled hypertension (>180/100 mmHg), 121 
angina, autonomic neuropathy, taking any medication that affects heart rate, major 122 
surgery planned within 6 weeks of the study, severe nonproliferative and unstable 123 
proliferative retinopathy. Testing took place in the laboratory of the School of Sport 124 
and Exercise Sciences at Liverpool John Moores University. The study was 125 
approved by the Black Country NHS Research Ethics Committee (West Midlands, 126 
UK) and all participants gave written informed consent to a protocol conforming to 127 
the Declaration of Helsinki.  128 
 129 
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Pre-training assessments 130 
Participants first performed an incremental exercise test to exhaustion on an 131 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, 132 
The Netherlands) to determine maximal aerobic power output (Wmax) and ?̇?O2peak 133 
using an online gas collection system (MOXUS modular oxygen uptake system, AEI 134 
technologies, Pittsburgh, PA). The test consisted of 3-minute stages starting at 60 W, 135 
and the workload was increased by 35 W at each stage until subjects could not 136 
maintain a cadence of >50 rpm, at which point the test was terminated. ?̇?O2peak was 137 
taken as the highest value achieved over a 15 second recording period.  Participants 138 
also completed a food diary over a minimum of three days in order to calculate 139 
habitual caloric and macronutrient intake. 140 
Three to 7 days after the incremental exercise test, participants attended the 141 
laboratory after an overnight fast (>10 h) for a second pre-training assessment 142 
session. Following 15 minutes rest, supine brachial artery blood pressure 143 
measurements were made in triplicate using an automated sphygmomanometer (GE 144 
DINAMAP Pro 300 V2). Aortic pulse wave velocity (aPWV) measurements were 145 
made using a semi-automated device and software (SphygmoCor, AtCor Medical, 146 
Sydney, Australia), as previously described by Cocks et al.15. A fasting blood sample 147 
was used to determine fasting plasma cholesterol and triglyceride concentrations, 148 
using a semi-automatic spectrophotometer (Randox RX Daytona™, County Antrim, 149 
UK).  150 
A Dexcom G4 Platinum (Dexcom, San Diego, CA, USA) CGMS probe was 151 
inserted subcutaneously into the abdomen. A habitual free-living 24h glucose profile 152 
was analysed at least 24 hours after the CGMS was inserted. Participants were 153 
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trained to use the CGMS and instructed to calibrate the device a minimum of four 154 
times daily using capillary blood tests. Participants were provided with a 155 
standardised diet of three meals (breakfast, lunch and dinner) during the CGMS 156 
period (50% CHO; 30% fat; 20% protein) in accordance with their habitual calorie 157 
intake. Participants were instructed to consume these meals at pre-determined time 158 
points throughout the day. No additional snacks were permitted and participants only 159 
consumed the food provided by the research team during this period, unless they 160 
needed to prevent hypoglycaemia (blood glucose <3.0 mmol/L)16. A food diary was 161 
completed to confirm that they had consumed the prescribed food at the correct 162 
times. Participants were instructed to avoid alcohol and caffeine, as well as exercise 163 
throughout the CGMS period.  164 
 165 
Exercise Training  166 
Training started ~72h after completion of the pre-experimental procedures. 167 
Participants trained three times per week for six weeks under researcher supervision 168 
on a Lode Corival cycle ergometer (Corival Lode BV, Groningen, The Netherlands). 169 
Following a 3-minute low-intensity warm-up, the HIT group performed repeated 1-170 
minute bouts of high intensity cycling at a workload equivalent to 100% ?̇?O2peak 171 
interspersed with 1 minute of recovery at 50 W, whereas the MICT group performed 172 
continuous moderate intensity cycling at a workload equivalent to 65% ?̇?O2peak. The 173 
number of intervals in the HIT group increased from 6 in weeks 1 and 2, to 8 in 174 
weeks 3 and 4 to 10 in weeks 5 and 6. The duration of the sessions in the MICT 175 
group were 30 minutes in weeks 1 and 2, 40 minutes in weeks 3 and 4 and 50 176 
minutes in weeks 5 and 6. 177 
 178 
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Acute change in blood glucose with exercise 179 
Participants were able to attend their training session between 7am and 5pm 180 
Monday to Friday. The amount and type of food was not controlled but we asked 181 
participants not to fast before exercising and not to exercise within 30 minutes of a 182 
meal with the aim being to study the effects of HIT and MICT under ‘real world’ 183 
conditions. Therefore, these training sessions are defined as being in the ‘fed’ state 184 
in this investigation. In line with advice that has been used in other studies17, and in 185 
keeping with international agreed advice18, if patients were doing MICT within 2 186 
hours of a meal they were asked to reduce their fast acting insulin at that meal by 187 
50%. No adjustments were made if doing a HIT session. Before starting and after 188 
completing each training session during the six-week training period, participant’s 189 
blood glucose concentrations were required to be between 7-14 mmol/L.  If blood 190 
glucose concentrations fell outside of this range corrective measures were taken; 191 
glucose was ingested if blood glucose <7 mmol/L, and a light walk or insulin bolus 192 
was advised if glucose >14 mmol/L, as well as checking blood ketones. In addition, 193 
when they first started exercising they were asked to check their glucose at 2am and 194 
to reduce their night time background insulin by 10%. Reduction of insulin at night 195 
could be continued if the participant found that their glucose was going low overnight 196 
on the day of exercise. All participants were asked to measure their blood glucose 197 
before and after an exercise session, in addition participants in the MICT arm were 198 
advised to check their blood glucose part-way through the exercise and to consume 199 
carbohydrate as necessary to prevent hypoglycaemia. Over the course of the 6 200 
weeks of training we gathered pre and post-exercise blood glucose concentrations 201 
from a total of 108 (86%) MICT training sessions and 87 (69%) HIT sessions. 202 
 203 
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Post-training assessments 204 
Approximately 72h after the final training session, participants attended the 205 
laboratory on two occasions (separated by 72h) to complete a series of post-training 206 
assessments.  These assessments were identical in all respects to those undertaken 207 
prior to training (pre-training assessments).   208 
 209 
Statistical analyses 210 
The primary outcome variable to measure a significant training benefit was ?̇?O2peak. 211 
Previous research in our group17,19 has suggested a SD of 2.7-3.2 to detect a 212 
change in ?̇?O2peak of 3.5 ml·kg
-1·min-1, which is a clinically significant increase in 213 
?̇?O2peak
20. A power calculation suggested that 7-9 participants were required in each 214 
group to detect a within-group difference with a paired t test with 80% power at a 215 
significance level of 0.05. Continuous glucose monitor data were downloaded from 216 
the device using Dexcom Studioᵀᴹ software (12.0.4.6) and analysed in accordance 217 
with the International Consensus on Use of Continuous Glucose Monitoring21. 218 
Glycaemic thresholds were defined as follows: target range (3.9-10 mmol/L), level 1 219 
hypoglycaemia (≤3.9 mmol/L), level 2 hypoglycaemia (≤2.9 mmol/L) and 220 
hyperglycaemia (≥10 mmol/L). The 24h period was defined as 08:00-08:00h and the 221 
nocturnal period was defined as 24:00-06:00h. All variables were analysed using a 222 
two-way mixed ANOVA, with the between factor ‘group’ (HIT vs. MICT) and repeated 223 
factor ‘training status’ (pre-training vs. post training), followed by Bonferroni post-hoc 224 
corrections. A two way mixed ANOVA, with the between factor ‘group’ and the 225 
repeated factor ‘time point’ (pre-training vs. post training) was used to assess 226 
whether there was an acute change in blood glucose concentration following HIT 227 
and MICT in the fed state over the 6 weeks of training. The CGMS did not work on 228 
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one participant in the MICT group. Aortic PWV readings were obtained from five 229 
participants in the HIT group and six in the MICT group. All analyses were performed 230 
using IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. Data 231 
are presented as mean ± SEM and significance was set at P≤0.05. 232 
 233 
RESULTS 234 
By design, there were no differences in age (P=0.877), ?̇?O2peak (P=0.371) or duration 235 
of type 1 diabetes (P=0.291) between the training groups at baseline. BMI was, 236 
however, significantly higher in the HIT group compared to the MICT group 237 
(P=0.038). Pre and post-training variables are presented in Table 1. Training 238 
increased ?̇?O2peak (HIT 14%, MICT 15%; P<0.001) and Wmax (HIT 13%, MICT 14%; 239 
P<0.001), with no difference between groups (Fig. 1). Six weeks of training also 240 
improved aPWV (P=0.001) and there was no difference between groups. Systolic, 241 
diastolic and mean arterial blood pressure did not improve following training 242 
(P=0.219; P=0.476; P=0.268, respectively). There was no change in plasma 243 
cholesterol or triglyceride concentrations with training (P=0.881; P=0.652, 244 
respectively). 245 
 246 
Glycaemic control 247 
Glucose data from the CGMS obtained over a 24h period pre- and post-training are 248 
presented in Table 2. There was no difference in the time spent in level 1 249 
hypoglycaemia (≤3.9 mmol/L) over the 24h period (P=0.727) or nocturnal period 250 
(P=0.289) with training. Similarly, there was no difference in time spent in level 2 251 
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hypoglycaemia (≤2.9 mmol/L) with training over the 24h period (P=0.442) or 252 
nocturnal period (P=0.397). There were also no differences in the time spent in 253 
target range over the 24h (P=0.412) or nocturnal periods (P>0.382). Furthermore, 254 
there was no difference in the time spent in hyperglycaemia over the 24h (P=0.540) 255 
or nocturnal period (P=0.118). However, there was an interaction effect for the time 256 
spent in target range (P=0.034) and time in hyperglycaemia over the nocturnal 257 
period (P=0.039). Post hoc analysis revealed that the HIT group spent significantly 258 
less time in target glycaemia during the nocturnal period (P=0.038) which was due to 259 
a greater time spent in hyperglycaemia over the nocturnal period (P=0.016). The 260 
incidence of level 1 hypoglycaemia over the 24h period (P=0.675) and nocturnal 261 
period (P=0.363) was no different before and after HIT or MICT. There were no 262 
differences in the incidence of level 2 hypoglycaemia over the 24h (P=0.174) or 263 
nocturnal (P=0.549) period following 6 weeks of HIT or MICT.  264 
 265 
Acute change in blood glucose during training sessions  266 
When quantifying the change in blood glucose concentration during exercise training 267 
sessions undertaken in the fed state over the six-week intervention, the mean 268 
change in blood glucose concentration in response to HIT was -0.2 ± 0.5 mmol/L 269 
(P<0.001) whereas blood glucose decreased by -5.5 ± 0.4 mmol/L in response to 270 
MICT (P=0.626; Fig. 2). 271 
 272 
DISCUSSION 273 
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This study demonstrates for the first time that six weeks of HIT improves ?̇?O2peak and 274 
aPWV in people with type 1 diabetes to a similar magnitude as MICT. Secondly, we 275 
observed that blood glucose concentration remained stable during the HIT sessions 276 
performed in the fed state throughout the training programme, but there was a 277 
consistently large drop in blood glucose during MICT throughout the training 278 
programme, with participants at risk of hypoglycaemia. The CGMS data revealed 279 
that 24 hour glucose was not affected by either form of training. However, overnight 280 
there was a decrease in the time spent in target range in the HIT group, due to an 281 
increase in time spent in hyperglycaemia, while there were no changes in glycaemic 282 
control in the MICT group. The fact that HIT is a time-efficient training mode that 283 
improved ?̇?O2peak and aPWV to a similar extent as MICT but did not cause a fall in 284 
glucose during exercise as was observed during MICT means that it may be a more 285 
practical exercise strategy for some patients with type 1 diabetes. However, the 286 
increase in nocturnal hyperglycaemia following HIT is of concern and suggests that 287 
people with type 1 diabetes may have to reduce their carbohydrate intake prior to 288 
and/or following HIT sessions or make changes to their night-time background 289 
insulin to prevent high glucoses overnight.  290 
Aerobic capacity improved to a similar extent following six weeks of HIT and 291 
MICT, despite the weekly time commitment being 54-90 minutes less for HIT than for 292 
MICT. The 14% increase in ?̇?O2peak observed in our investigation following HIT (a 293 
mean increase of 4.9 ml·kg-1·min-1) is high in comparison to other studies using 294 
similar protocols that tend to report changes of 7-10% in populations without type 1 295 
diabetes22 and the only other study to examine the effect of sprint interval training in 296 
people with type 1 diabetes (repeated 30-second maximal cycling bouts interspersed 297 
with 3-4 minutes of rest 3 times a week for 7 weeks) reported a 7% increase in 298 
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?̇? O2peak
23. This has clinical importance given that ?̇? O2max is reported to be the 299 
strongest prognostic marker of cardiovascular mortality20 and improvements 300 
in ?̇?O2max with exercise training are associated with a reduction in all-cause mortality 301 
risk24. In fact, Myers20 found that there is a 8-17% reduction in all-cause mortality for 302 
each 1-MET (~3.5 ml·kg-1·min-1) increase in ?̇? O2max. Although these correlations 303 
have not been specifically confirmed in people with type 1 diabetes, it is likely that 304 
the HIT programme used here induces clinically meaningful benefits to this 305 
population, which is especially important as they are at increased risk of 306 
cardiovascular disease compared to a non-diabetic population1,2.  307 
In the present study there was a 12% reduction in aPWV following both 308 
training modes, which is greater than has previously been reported in other training 309 
studies in populations without type 1 diabetes25,26. To the authors’ knowledge, this is 310 
the first study to investigate changes in arterial stiffness following HIT and MICT in 311 
people with type 1 diabetes. The reduction in aPWV is of clinical relevance as 312 
increased arterial stiffness is associated with negative cardiovascular outcomes27.  313 
Neither training mode improved glycaemic control according to the CGMS 314 
data, measured as time spent in target range (euglycaemia) or hypoglycaemia or the 315 
incidences of hypoglycaemia. Previous studies using HbA1c and daily insulin dosage 316 
as a marker of glycaemic control have also failed to show overall improvements in 317 
glycaemic control with exercise training23,28,29, although studies reporting positive 318 
effects of training on glycaemic control do exist30. There was a reduction in the time 319 
spent in euglycaemia overnight in the HIT group which was due to an increase in the 320 
time spent in hyperglycaemia. Although increasing the proportion of time spent in 321 
hyperglycaemia during the nocturnal period is not desirable, it did reduce the risk of 322 
developing hypoglycaemia which may mean that HIT is a preferable form of training 323 
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for those concerned about hypoglycaemia during exercise. The increased time spent 324 
in hyperglycaemia overnight with HIT is concerning, given that this will increase the 325 
risk of long term complications so needs to be explored further in the future. There 326 
are three potential reasons for this rise in glycaemia with HIT. Firstly, due to an 327 
increase in adrenaline and noradrenaline post exercise. However, although this may 328 
explain the higher glucose levels just after exercise, this is unlikely to explain the 329 
higher nocturnal glycaemia as these hormones fall rapidly after cessation of exercise. 330 
This is further supported by another study performed in our laboratory (Scott et al. 331 
under review in JCEM), that used CGMS to show that an acute bout of HIT did not 332 
increase glucose post exercise or in the overnight period. A second reason may be 333 
that participants consumed too much carbohydrate in the HIT condition as the total 334 
workload of HIT is less than MICT meaning that less glucose is removed from the 335 
blood to replenish muscle and liver glycogen stores. Thirdly, there may have been 336 
inadequate background insulin overnight. At the start of training, participants were 337 
asked to reduce their overnight background insulin by 10%. Thereafter, whether they 338 
did this was dependent on their blood glucose concentration before they went to bed, 339 
their blood glucose on the previous days after training, and how concerned they 340 
were about going low overnight. It may be that participants reduced their overnight 341 
background insulin when this was not required. Unfortunately, we did not record their 342 
insulin dosages so do not know if this happened. Although the use of CGMS in our 343 
investigation allowed a detailed analysis of glycaemic control, we acknowledge that 344 
longer duration exercise training programmes with larger sample sizes are needed to 345 
assess the effects of exercise training on long-term glycaemic control. Furthermore, 346 
the current guidelines suggest that a minimum of 14 consecutive days should be 347 
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recorded when analysing CGMS data21. Unfortunately, these guidelines were 348 
published after our data collection was completed so will be used in future studies. 349 
Before the training sessions, we recorded blood glucose concentration for 350 
safety reasons to prevent participants from exercising when glucose concentrations 351 
were too high or low based on the EXTOD guidelines31. Blood glucose was also 352 
recorded after the sessions so that participants did not leave the laboratory while 353 
they were potentially at increased risk of hypoglycaemia. This meant that we 354 
collected pre and post-exercise blood glucose readings from up to 18 training 355 
sessions for each participant over the course of six weeks of HIT or MICT. We 356 
collected pre and post-exercise blood glucose concentrations from a total of 108 357 
(86%) MICT training sessions and 87 (69%) HIT sessions. During the HIT sessions 358 
glucose remained stable throughout the training programme whereas during MICT 359 
sessions there was a consistently large fall in glucose. This was a consistent 360 
observation across all participants undertaking MICT (Fig. 2b). Readings from at 361 
least 9 sessions were available for every participant and the clear differences 362 
between the groups and the low standard deviation for the changes in blood glucose 363 
suggest the results were not affected by the different number of readings per group. 364 
The changes in blood glucose concentration during the exercise reported here are 365 
striking and are the first of their kind in the literature over so many training sessions. 366 
Furthermore, they are supported by Garcia-Garcia et al.32 who conducted a 367 
systematic review and meta-analysis in which they aggregated results from 10 368 
studies to estimate rate of change of glucose concentration during and after different 369 
types of exercise in people with type 1 diabetes. Their results showed a rapid decline 370 
in glycaemia during continuous exercise (-4.43 mmol/L h-1 on average) while the 371 
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results were more variable during intermittent high intensity exercise depending on 372 
the protocol.  373 
The drop in blood glucose concentration during the MICT sessions is likely 374 
due to the effects of short-acting insulin in the circulation. In healthy individuals, 375 
blood glucose concentration remains stable during moderate-intensity aerobic 376 
exercise because insulin secretion is suppressed progressively with exercise 377 
duration and there is a gradual increase in glucagon and adrenaline resulting in 378 
increased hepatic glucose production33,34. Therefore, contraction-mediated glucose 379 
uptake is matched by increased hepatic glucose production so that blood glucose 380 
concentration remains stable at ~4.0-6.0 mmol/L33. However, as insulin is supplied 381 
exogenously in people with type 1 diabetes, hyperinsulinaemia is likely to occur 382 
because of increased blood flow and mobilisation of insulin from its subcutaneous 383 
depot, particularly if the injection site is in an exercised region33. This results in 384 
enhanced glucose uptake due to combined contraction-mediated and insulin-385 
stimulated GLUT4 translocation. The high insulin levels will also suppress the 386 
exercise-mediated increases in glucagon and adrenaline and their ability to stimulate 387 
hepatic glucose production35. As a result, muscle glucose uptake during MICT will 388 
exceed hepatic glucose production, leading to the large decreases in plasma 389 
glucose concentration observed in this study (Fig. 2). Hyperinsulinaemia has also 390 
been shown to suppress adipose tissue and intramuscular triglyceride (IMTG) 391 
lipolysis in healthy individuals36, which will reduce the contribution of lipids to the fuel 392 
mixture oxidised during exercise. The combination of insulin and exercise-mediated 393 
glucose disposal coupled with decreased hepatic glucose production and reduced 394 
lipolysis and lipid oxidation increases the risk of hypoglycaemia during MICT. On the 395 
other hand, the stable blood glucose concentrations following HIT are likely due to 396 
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greater plasma catecholamine (particularly noradrenaline) concentrations which lead 397 
to an increase in hepatic glucose production, thus offsetting the effects of 398 
hyperinsulinaemia37. Previous research has shown that addition of a sprint to a bout 399 
of moderate-intensity exercise in individuals with type 1 diabetes opposed the fall in 400 
glycaemia during exercise and this was associated with a rise in catecholamines38. 401 
Following a bout of HIT, it may be speculated that the greater catecholamine 402 
response compared to MICT may lead to stimulation of adipose tissue lipolysis and 403 
increase oxidation of the released fatty acids in the muscle during recovery39.  404 
Another important observation, although not quantitatively reported here, was 405 
the number of training sessions in which participants had to prevent or treat an 406 
episode of hypoglycaemia by consuming fast-acting carbohydrate. During the MICT 407 
sessions, participants were advised to stop exercising at least once to check their 408 
blood glucose concentration in accordance with the EXTOD guidelines31, correct 409 
accordingly with glucose if necessary, and then wait for their blood glucose to 410 
stabilise before recommencing the training. Many of the participants in the MICT 411 
condition found this frustrating and it would often mean that the already time 412 
consuming 50-minute cycling sessions were even longer while blood glucose was 413 
checked. The large drop in blood glucose concentration that we found during the 414 
MICT sessions highlights why the guidelines recommend that carbohydrate should 415 
be taken when doing more than 30 minutes of moderate-intensity exercise40. 416 
Therefore, these findings provide evidence that HIT may be a more practical form of 417 
exercise for people with type 1 diabetes that regularly experience problems with 418 
hypoglycaemia during exercise.  419 
The main strengths of this investigation were 1) the strict dietary 420 
standardisation under free-living conditions during the CGMS period pre and post-421 
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training, and 2) the monitoring of acute changes in blood glucose concentrations 422 
during exercise throughout the intervention. We also acknowledge that there are 423 
some limitations. The sample size of the study was small; however, the clear 424 
significant increases in ?̇?O2peak suggest that we have the power to conclude that HIT 425 
is effective at improving ?̇?O2peak in people with type 1 diabetes. Secondly, we did not 426 
record insulin dose before and after the training intervention. This would be useful to 427 
determine whether there is a change in insulin sensitivity as reduced insulin dosage 428 
is associated with decreased risk of cardiovascular complications in people with type 429 
1 diabetes41,42. 430 
In summary, this is the first study to demonstrate that six weeks of HIT leads 431 
to comparable improvements in ?̇?O2peak and arterial stiffness to MICT. HIT though 432 
may be the preferred exercise approach, as blood glucose remains stable during HIT, 433 
but falls substantially during MICT. We therefore recommend that HIT in the fed state 434 
is a safe, effective, flexible and time-efficient form of exercise for people with type 1 435 
diabetes. 436 
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Table 1 - General characteristics 606 
 HIT  MICT 
 Pre Post  Pre Post 
Age (years) 29 ± 3 -  29 ± 5 - 
Sex 5M/2F -  5M/2F - 
Duration of T1D 
(years) 
13 ± 3 -  9 ± 2 - 
Mass (kg) 90.0 ± 4.8 89.8 ± 4.8  76.7 ± 5.4 76.3 ± 5.3 
BMI (kg∙m-2) 29.2 ± 1.2 29.2 ± 1.2  25.3 ± 1.2 25.2 ± 1.2 
?̇?O2peak (ml∙kg
-1∙min-
1) 
35.6 ± 2.6 40.5 ± 2.6*  32.1 ± 2.6 36.9 ± 3.2* 
?̇?O2peak (L/min
-1) 3.2 ± 0.3 3.7 ± 0.3*  2.5 ± 0.3 2.9 ± 0.4* 
Wmax (W) 245 ± 16 277 ± 19*  202 ± 22 231 ± 24* 
SBP (mmHg) 121 ± 3 119 ± 4  123 ± 4 122 ± 4 
DBP (mmHg) 65 ± 3 63 ± 3  70 ± 5 68 ± 4 
MAP (mmHg) 84 ± 3 82 ± 2  87 ± 4 86 ± 3 
aPWV (m/s) 6.1 ± 0.5 5.4 ± 0.7*  6.1 ± 0.4 5.4 ± 0.4* 
Cholesterol (mmol/L) 5.07 ± 0.29 5.12 ± 0.35  4.81 ± 0.41 4.93 ± 0.41 
Triglycerides (mmol/L) 0.94 ± 0.09 1.03 ± 0.25  0.70 ± 0.04 0.65 ± 0.06 
 607 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood 608 
pressure; MAP = mean arterial pressure; aPWV = arterial pulse wave velocity. Data 609 
are presented as mean ± SEM. *Denotes a significant change from pre-training to 610 
post-training (P<0.05). 611 
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Table 2 - Summary of continuous glucose monitor data  612 
 HIT  MICT 
 Pre Post  Pre Post 
24h period      
Mean glucose (mmol/L) 9.3±0.3 9.5±1.0  9.2±0.6 8.6±0.7 
CV (%) 42.6±3.6 38.2±2.6  37.9±3.6 36.9±4.0 
Time in level 1 
hypoglycaemia (%) 
6.1±2.6 5.4±3.1  3.4±1.5 2.8±1.9 
Time in level 2 
hypoglycaemia (%) 
0.2±0.2 0.5±0.3  0.9±0.5 0.0±0.0 
Time in range (%) 56.7±3.1 56.4±7.8  59.3±5.8 68.2±7.7 
Time in hyperglycaemia  
(%) 
37.0±2.0 37.7±8.9  36.3±6.5 28.9±8.5 
Incidence of level 1 
hypoglycaemia 
1.8±0.6 1.2±0.5  0.9±0.5 1.4±0.6 
Incidence of level 2 
hypoglycaemia 
0.2±0.2 0.2±0.2  0.4±0.2 0.1±0.1 
Incidence of 
hyperglycaemia 
3.0±0.5 2.8±0.5  3.2±0.5 2.5±0.5 
Nocturnal period      
Mean glucose (mmol/L) 8.8±1.3 11.7±2.0  8.0±1.2 7.4±1.1 
CV (%) 23.2±5.9 19.5±9.1  29.1±7.2 22.2±6.2 
Time in level 1 
hypoglycaemia (%) 
9.3±9.0 3.0±2.0  7.6±5.0 4.9±4.9 
Time in level 2 0.0±0.0 1.2±1.2  3.2±2.0 0.0±0.0 
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hypoglycaemia (%) 
Time in range (%) 57.4±15.5 32.6±14.3*  60.0±15.4 71.3±16.5 
Time in hyperglycaemia  
(%) 
33.3±16.7 63.0±16.3*  28.5±15.9 23.6±15.8 
Incidence of level 1 
hypoglycaemia 
0.5±0.2 0.3±0.2  0.3±0.2 0.1±0.1 
Incidence of level 2 
hypoglycaemia 
0.0±0.0 0.2±0.2  0.3±0.2 0.0±0.0 
Incidence of 
hyperglycaemia 
0.5±0.2 0.8±0.2  0.5±0.2 0.3±0.2 
 613 
The 24h period was defined as 08:00-08:00h and nocturnal period as 24:00-06:00h. 614 
Level 1 hypoglycaemia (≤3.9 mmol/L), level 2 (severe) hypoglycaemia (≤2.9 mmol/L), 615 
target range (3.9-10 mmol/L) and hyperglycaemia (≥10 mmol/L). There were no 616 
differences in any of the variables with training (P>0.05). 617 
 618 
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 627 
 628 
Figure 1 – Effect of six weeks of high intensity interval training (HIT) and moderate 629 
intensity continuous training (MICT) on ?̇?O2peak.  630 
(A) Shows the mean responses and (B) shows individual responses in ?̇?O2peak with 631 
training. *Indicates a significant difference from baseline (P<0.05).  632 
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 639 
Figure 2 - Change in blood glucose following exercise in the fed state 640 
Finger prick blood glucose concentrations were recorded immediately before and 641 
after exercise. As such, over the course of the six weeks of training we gathered pre 642 
and post exercise blood glucose concentrations from a total of 108 MICT training 643 
sessions and 87 HIT sessions in the fed state (86% and 69% of total possible 644 
sessions, respectively). Mean change in blood glucose concentration (A) and 645 
average change in blood glucose concentration during HIT and MICT over the 6 646 
week training period (B). *Denotes a significant change from baseline (P<0.05). 647 
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